"BIG PHARMA" IN OUR BEDROOMS: AN ANALYSIS OF THE MEDICALIZATION OF WOMEN'S SEXUAL PROBLEMS

Advances in Gender Research

Volumn 7, Issue , 2003, Pages 89-129

  Hartley, Heather ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745266644     PISSN: 15292126     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1529-2126(03)07004-8     Document Type: Review

References (83)

1. Abbott, A. (1988). The system of professions . Chicago: University of Chicago Press.
2. Altman, L. (1997). Experts see bias in drug data. The New York Times , p. C1, C8.
3. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: APA.
4. J Anderson The deprofessionalization of American medicine Current Research on Occupations and Professions 7 1992 241 256
5. M Angell Is academic medicine for sale? The New England Journal of Medicine 342 20 2000 1516 1518
6. M Angell The pharmaceutical industry: To whom is it accountable? The New England Journal of Medicine 342 25 2000 1902 1904
7. W Arlt F Callies J Vlijmen Dehydroepiandrosterone replacement in women with adrenal insufficiency New England Journal of Medicine 341 1999 1013 1020
8. R Basson J Berman A Burnett L Derogatis D Ferguson J Fourcroy Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications Journal of Urology 163 2000 888 892
9. Basson, R., Bourgeois-Law, G., Fourcroy, J., Heiman, J., Priestman, A., Rowe, T., Stevenson, R., Thomson, S., & Tiefer, L. (2001). Androgen “deficiency” in women is problematic. Medical Aspects of Human Sexuality , 45–47. http://www.medicalsexuality.org
10. Belkin, L. (2001). Prime time pushers. Mother Jones (March/April), 31–37.
11. S Bell Changing ideas: The medicalization of menopause Social Science and Medicine 24 6 1987 535 542
12. S Bell Sociological perspectives on the medicalization of menopause Annals New York Academy of Sciences 592 1990 173 178
13. Berman, J., & Berman, L. (with Elisabeth Bumiller) (2001). For women only: A revolutionary guide to overcoming sexual dysfunction and reclaiming your sex life . New York: Henry Holt and Company.
14. T Bodenheimer Uneasy alliance: Clinical investigators and the pharmaceutical industry The New England Journal of Medicine 342 20 2000 1539 1544
15. Bodenheimer, T. (2002). Research bias in clinical drug trials. The New female sexual dysfunction: Promises, prescriptions, and profits (conference). San Francisco, CA. March 9th, 2002.
16. Boston University School of Medicine, Female Sexual Function Forum: New Perspectives in the Management of Female Sexual Dysfunction. CME Conference proceedings, October 26th–29th, 2000.
17. Boston University School of Medicine, Female Sexual Function Forum: New Perspectives in the Management of Female Sexual Dysfunction. CME Conference proceedings, October 25th–28th, 2001.
18. Coney, S. (1994). The menopause industry . Alameda: Hunter House.
19. P Conrad Medicalization and social control Annual Review of Sociology 18 1992 209 232
20. Cowley, G. (2000). Looking beyond viagra. Newsweek , April 24th.
21. D Davis P McCloud B Straus H Burger Testosterone enhances estradiol’s effects on postmenopausal bone density and sexuality Maturitas 21 1995 227 236
22. C DeAngelis Conflict of interest and the public trust Journal of the American Medical Association 284 17 2000 2237 2238
23. Dennerstein, L. (2001). Female androgen deficiency syndrome: Definition, diagnosis, and classification (on-line). Available: http://www.medscape.com/Medscare/CNO/2001/Androgen/pnt-Androgen.html
24. A Donchlin Feminist critiques of new fertility technologies: Implications for social policy The Journal of Medicine and Philosophy 21 1996 475 498
25. Figert, A. (1996). Women and the ownership of PMS . Hawthorne: Aldine de Gruyter.
26. Findlay, D., & Miller, L. (1994). Through medical eyes: The medicalization of women’s bodies and women’s lives. In: B. S. Bolaria & H. Dickinson (Eds), Health, Illness and Health Care in Canada (2nd ed., pp. 276–305). Toronto: Harcourt Brace.
27. Food and Drug Administration (FDA) (2000). Guidance for industry. Female sexual dysfunction: Clinical development of drug products for treatment (on-line). Available: http://www.fda.gov/cder/guidance/index/htm
28. Fourcroy, J. (2000). Diagnostic challenges – Female androgen deficiency syndrome. Female Sexual Function Forum (FSFF). October 26th–29th, 2000. Boston, MA.
29. Fourcroy, J. (2001). Androgen deficiency syndrome in women: Implications, mechanisms and treatments. Female Sexual Function Forum (FSFF). October 25th–28th, 2001. Boston, MA.
30. Freidson, E. (1970). Professional dominance: The social structure of medical care . New York: Atherton Press.
31. Guay, A. (2001). Advances in the management of androgen deficiency in women (on-line). Available: http://www.medicalsexuality.org
32. Hafferty, F., & Light, D. (1995). Professional dynamics and the changing nature of medical work. Journal of Health and Social Behavior (Extra), 132–153.
33. H Hartley Influence of managed care on supply of certified nurse-midwives: An evaluation of the physician dominance thesis Journal of Health and Social Behavior 40 1999 87 101
34. H Hartley Promising liberation but delivering business as usual? Sexualities 5 1 2002 107 113
35. H Hartley L Tiefer Taking a biological turn: The push for a “female Viagra” and the medicalization of women’s sexual problems Women’s Studies Quarterly 31 2003 42 54
36. M Haug Deprofessionalization: An alternative hypothesis for the future Sociological Review Monographs 20 1973 195 211
37. M Haug B Lavin Practitioner or patient – Who’s in charge? Journal of Health and Social Behavior 22 1981 212 229
38. E Hoen Direct-to-consumer advertising: For better profits or better health? American Journal of Health-System Pharmacy 55 6 1998 594 607
39. J Hoffman M Wilkes Direct to consumer advertising of prescription drugs: An idea whose time should not come British Medical Journal 318 1999 1301 1302
40. M Hollon Direct-to-consumer marketing of prescription drugs: Creating consumer demand Journal of the American Medical Association 281 4 1999 382 384
41. A Holmer Direct-to-consumer prescription drug advertising builds bridges between patients and physicians Journal of the American Medical Association 281 4 1999 380 382
42. R Horton The tightening grip of big pharma Lancet 357 2001 1141
43. Kaiser Family Foundation (2001). http://www.kff.org/content/2001/200111291/ ; consulted on 12/07/01.
44. Kaschak, E., & Tiefer, L. (Eds) (2001). A new view of women’s sexual problems . New York: Haworth Press.
45. Kennedy, D. (1997). Academic duty . Cambridge: Harvard University Press.
46. Larson, M. (1977). The rise of professionalism: A sociological analysis . Berkeley: University of California Press.
47. E Laumann A Paik R Rosen Sexual dysfunction in the United States: Prevalence and predictors Journal of the American Medical Association 281 6 1999 537 544
48. J Leavitt The medicalization of childbirth in the twentieth century, Transactions Transactions & Studies of the College of Physicians of Philadelphia 5 11:4 1989 299 319
49. Leland, J. (2000). The science of women and sex. Newsweek , May 29th.
50. Light, D. (2000). The medical profession and organizational change: From professional dominance to countervailing power. In: C. Bird, P. Conrad & A. Fremont (Eds), Handbook of Medical Sociology (5th ed., pp. 201–216). Prentice-Hall.
51. M Lipsky C Taylor The opinions and experiences of family physicians regarding direct-to-consumer advertising The Journal of Family Practice 45 6 1997 495 499
52. R Lobo Androgens in postmenopausal women: Production, possible role, and replacement options Obstetrical & Gynecological Survey 56 2001 361 376
53. Maines, R. (1999). The technology of orgasms: “Hysteria”, the vibrator, and women’s sexual satisfaction . Baltimore and London: Johns Hopkins University Press.
54. S Marken The problematic of “experience”: A political and cultural critique of PMS Gender and Society 10 1 1996 42 58
55. J McKinlay The changing character of the medical profession: Introduction Milbank Quarterly 66 Suppl. 2 1988 1 9
56. J McKinlay J Arches Towards the proletarianization of physicians International Journal of Health Services 15 1985 161 195
57. E Oinas Medicalization by whom? Accounts of menstruation conveyed by young women and medical experts in medical advisory columns Sociology of Health and Illness 20 1 1998 52 70
58. K Pugliesi Premenstrual syndrome: The medicalization of emotion related to conflict and chronic role strain Humboldt Journal of Social Relations 18 2 1992 131 165
59. Randolph, J., & Dennerstein, L. (2001). Female androgen deficiency syndrome: A hard look at a sexy issue. Medscape Women’s Health , 6 (2).
60. A Relman Separating continuing medical education from pharmaceutical marketing Journal of the American Medical Association 285 15 2001 2009 2111
61. A Rich Compulsory heterosexuality and lesbian existence Signs 5 1980 647 650
62. C Riessman Women and medicalization: A new perspective Social Policy 14 1983 3 18
63. J Shifren G Braunstein J Simon Transdermal testosterone treatment in women with impaired sexual function after oophorectomy New England Journal of Medicine 343 2000 682 688
64. Slaughter, S., & Leslie, L. (1997). Academic capitalism: Politics, policies, and the entrepreneurial university . Baltimore: Johns Hopkins University Press.
65. Spilker, B. (2002). The drug development and approval process (on-line). Available: http://www.phrma.org/searchcures/newmeds/devapprovprocess.phtml
66. D Sullivan Cosmetic surgery: Market dynamics and medicalization Research in the Sociology of Health Care 10 1993 97 110
67. Starr, P. (1982). The social transformation of American medicine . New York: Basic Books.
68. T Terzian Direct-to-consumer prescription drug advertising American Journal of Law and Medicine 25 1999 149 167
69. L Tiefer The medicalization of impotence: Normalizing phallocentrism Gender and Society 8 3 1994 363 377
70. Tiefer, L. (1995). Sex is not a natural act, and other essays . Boulder: Westview.
71. L Tiefer The medicalization of sexuality: Conceptual, normative, and professional issues Annual Journal of Sex Research 7 1996 252 282
72. L Tiefer Sexology and the pharmaceutical industry: The threat of co-optation The Journal of Sex Research 37 3 2000 273 283
73. L Tiefer The consensus conference on female sexual dysfunction: Conflicts of interest and hidden agendas Journal of Sex & Marital Therapy 27 2 2000 227 236
74. Tiefer, L. (2001). Arriving at a new view of women’s sexual problems: Background, theory, and activism. In: E. Kaschak & L. Tiefer (Eds), A New View of Women’s Sexual Problems (pp. 63–98). New York: Haworth Press.
75. Tiefer, L. (2002). Female sexual dysfunction: Where’d it come from and where’s it going? The new female sexual dysfunction: Promises, prescriptions, and profits (conference). San Francisco, CA, March 9th, 2002.
76. Tolman, D., & Higgins, T. (1996). How being a good girl can be bad for girls. In: A. Maglin & D. Perry (Eds), Bad Girls, Good Girls: Women, Sex, and Power in the Nineties (pp. 205–225). New Brunswick, NJ: Rutgers University Press.
77. Ussher, J., & Baker, C. (Eds) (1993). Psychological perspectives on sexual problems: New directions in theory and practice . New York: Routledge.
78. Vance, C. (Ed.) (1984). Pleasure and danger: Exploring female sexuality . Boston: Routledge and Kegan Paul.
79. Washburn, J. (2001). Undue influence: How the drug industry’s power goes unchecked and why the problem is likely to get worse. American Prospect (August 13th), 16–22.
80. A Wazana Physicians and the pharmaceutical industry Journal of the American Medical Association 283 2000 373 380
81. Weitz, R. (Ed.) (1998). The politics of women’s bodies: Sexuality, appearance and behavior . New York: Oxford University Press.
82. Wilkes, M., Bell, R., & Kravitz, R. (2000). Drug research and development: Direct-to-consumer prescription drug advertising. Health Affairs (March/April), 110–128.
83. I Zola Medicine as an institution of social control Sociological Review 20 1972 487 504